PDL BioPharma, Inc. Financial and Nonfinancial Liabilities, Fair Value Disclosure
PDL BioPharma, Inc. had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $0 as of 2019-12-31, per its 8-K filed 2020-06-29.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2020-06-29
- 2019-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2018-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $1.07M.
- 2017-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $42.00M.
- 2016-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $130.65M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2019-12-31 | $0.00 8-K · filed 2020-06-29 |
| 2018-12-31 | $1.07M 8-K · filed 2020-06-29 |
| 2017-12-31 | $42.00M 10-K · filed 2019-03-15 |
| 2016-12-31 | $130.65M 10-K · filed 2018-03-16 |